emerging treatment options for lower- and higher-risk mds and ongoing trials
Published 1 year ago • 84 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
3:31
promising treatment options emerging for higher-risk mds & the value of clinical trials
-
1:08
approved and emerging treatment options for transplant-ineligible patients with high-risk mds
-
11:33
treatment algorithm for low-risk mds
-
3:38
a new set of treatment options for low-risk mds
-
2:07
emerging targeted treatments for mds
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
1:02
update on treatments for high- and low-risk mds
-
1:45
a phase ii study of elritercept for lower-risk mds
-
1:20
the current standard of care for patients with lower-risk mds
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
2:06
outcomes & promising treatment options following hma failure in patients with hr-mds
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
5:43
pre- and post-allohsct treatment in mds
-
1:16
state of the art: mds
-
1:32
next-generation sequencing for low-risk mds
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
1:57
realigning mds treatment goals
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
2:16
current and future treatment approaches for hr-mds